Behavioral Health

HHS announces funding for development of PTSD treatment, study on emerging mental illness remedies

By Industry News 1 min read

The Department of Health and Human Services Nov. 12 made two announcements  regarding the development of mental health treatments for veterans and other individuals. The agency announced it would fund up to $4.9 million through the Advanced Research Projects Agency for Health to advance the development of ibogaine as a potential treatment for post-traumatic stress disorder and other serious mental illnesses for veterans and others. HHS also announced that the National Institute of Mental Health issued a funding notice of $20 million to support the development of a research network to study rapid-acting psychotropic interventional drugs, such as ketamine, esketamine, psilocybin and other emerging treatments for serious mental illnesses. The agency said award recipients will be announced in the summer of 2027. From AHA.org — Read More

Share this post

Integrated Psychiatric Consultants

Office Hours:
Mon-Fri, 9 a.m. - 5 p.m. CT

Reach out today.

Integrated Psychiatric Consultants (IPC) is committed to protecting and respecting your privacy. Our team will use the information collected here solely to serve your needs and notify you about relevant services. To consent, please check the box above and submit this form.

Please note, this consent applies to all forms of communications, including SMS. If you have provided a mobile phone number above, you agree to receiving SMS messages from IPC. You may unsubscribe at any time. Message frequency varies. Messaging and data rates may apply. Reply STOP to cancel. For more information, please review our Privacy Policy.